Sera from Guillain-Barré patients enhance leakage in blood-nerve barrier model

Neurology

Volumn 60, Issue 2, 2003, Pages 301-306

  Kanda, Takashi ^a   Yamawaki, Masanaga ^b   Mizusawa, Hidehiro ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; CARBOXYL GROUP; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; INULIN;

ADULT; ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; BLOOD NERVE BARRIER; CATTLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; INULIN CLEARANCE; MALE; MEMBRANE PERMEABILITY; MICROVASCULATURE; MODEL; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; SERUM;

EID: 0037469166     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000041494.70178.17     Document Type: Article

References (29)

1. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome. Plasma exchange in Guillain-Barré syndrome: one-year follow-up. Ann Neurol 1992;32:94-97.
2. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome. Appropriate number of plasma exchange in Guillain-Barré syndrome. Ann Neurol 1997;41:298-306.
3. Quarles RH, Weiss MD. Autoantibodies associated with peripheral neuropathy. Muscle Nerve 1999;22:800-822.
4. Kusunoki S. Antiglycolipid antibodies in Guillain-Barré syndrome and autoimmune neuropathies. Am J Med Sci 2000;319:234-239.
5. Sharief MK, Ingram DA, Swash M. Circulating tumor necrosis factoralpha correlates with electrodiagnostic abnormalities in Guillain-Barré syndrome. Ann Neurol 1997;42:68-73.
6. Oomes PG, van der Meche FG, Markus-Silvus L, Meulstee J, Kleyweg RP. In vitro effects of sera from Guillain-Barré subgroups: an electrophysiological and histological study on rat nerves. Muscle Nerve 1991;14:1013-1020.
7. Sawant-Mane S, Clark MB, Koski CL. In vitro demyelination by serum antibody from patients with Guillain-Barré syndrome requires terminal complement complexes. Ann Neurol 1991;29:397-404.
8. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27(suppl):21-24.
9. Plasma Exchange/Sandglobulin Guillain-Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 1997;349:225-230.
10. Kanda T, Iwasaki T, Yamawaki M, Ikeda K. Isolation and culture of bovine endothelial cells of endoneurial origin. J Neurosci Res 1997;49:769-777.
11. Kanda T, Yoshino H, Ariga T, Yamawaki M, Yu RK. Glycosphingolipid antigens in cultured bovine brain microvascular endothelial cells: sulfoglucuronosyl paragloboside as a target of monoclonal IgM in demyelinative neuropathy. J Cell Biol 1994;126:235-246.
12. Iwasaki T, Kanda T, Mizusawa H. Effects of pericytes and various cytokines on integrity of endothelial monolayer originated from bloodnerve barrier: an in vitro study. J Med Dent Sci 1999;46:31-40.
13. Kanda T, Iwasaki T, Yamawaki M, Tai T, Mizusawa H. Anti-GM1 antibody facilitates leakage in an in vitro blood-nerve barrier model. Neurology 2000;55:585-587.
14. Hahn AF, Feasby TE, Wilkie L, Lovgren D. Antigalactocerebroside antibody increases demyelination in adoptive transfer experimental allergic neuritis. Muscle Nerve 1993;16:1174-1180.
15. Spies JM, Pollard JD, Bonner JG, Westland KW, McLeod JG. Synergy between antibody and P2-reactive T cells in experimental allergic neuritis. J Neuroimmunol 1995;57:77-84.
16. Simmons RD, Buzbee TM, Linthicum DS. An immunohistological study of autoimmune encephalomyelitis and neuritis in the rabbit. Observations in the dorsal root ganglion using the freeze-dried paraffin-embedded tissue technique. J Neurol Sci 1988;83:293-304.
17. Wang W, Merrill MJ, Borchardt RT. Vascular endothelial growth factor affects permeability of brain microvessel endothelial cells in vitro. Am J Physiol 1996;271:C1973-C1980.
18. Hurst RD, Fritz IB. Properties of an immortalised vascular endothelial/glioma cell co-culture model of the blood-brain barrier. J Cell Physiol 1996;167:81-88.
19. Dhib-Jalbut S, Jiang H, Williams GJ. The effect of interferon beta-1b on lymphocyte-endothelial cell adhesion. J Neuroimmunol 1996;71:215-222.
20. Kanda T, Yamawaki M, Iwasaki T, Mizusawa H. Glycosphingolipid antibodies and blood-nerve barrier in demyelinative neuropathy. Neurology 2000;54:1459-1464.
21. Creange A, Belec L, Clair B, Degos JD, Raphael JC, Gherardi RK. Circulating transforming growth factor beta 1 (TGF-beta 1) in Guillain-Barré syndrome: decreased concentrations in the early course and increase with motor function. J Neurol Neurosurg Psychiatry 1998;64:162-165.
22. Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 1996;347:702.
23. Dyer CA. Novel oligodendrocyte transmembrane signaling systems. Investigations utilizing antibodies as ligands. Mol Neurobiol 1993;7:1-22.
24. Kanda T, Owada K, Iwasaki T, Yamawaki M, Mizusawa H. Anti-GM1 antibody activates NF-kB and increases nitric oxide secretion in cultured endothelial cells forming blood-nerve barrier. Ann Neurol 2001;50(suppl 1):S22.
25. Kanda T, Hayashi H, Tanabe H, Tsubaki T, Oda M. A fulminant case of Guillain-Barré syndrome: topographic and fibre size related analysis of demyelinating changes. J Neurol Neurosurg Psychiatry 1989;52:857-864.
26. Oliver JA. Adenylate cyclase and protein kinase C mediate opposite actions on endothelial junctions. J Cell Physiol 1990;145:536-542.
27. Pardridge WM, Eisenberg J, Yang J. Human blood-brain barrier transferrin receptor. Metabolism 1987;36:892-895.
28. Broadwell RD, Balin BJ, Salcman M. Transcytotic pathway for bloodborne protein through the blood-brain barrier. Proc Natl Acad Sci USA 1988;85:632-636.
29. Villegas JC, Broadwell RD. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. II. Adsorptive transcytosis of WGA-HRP and the blood-brain and brain-blood barriers. J Neurocytol 1993;22:67-80.